iRhythm Holdings Inc. (IRTC)
NASDAQ: IRTCHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
IRTC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $3.18B
- Forward P/E
- 61.64
- EPS (TTM)
- -$1.17
- Dividend yield
- None
- 52-week range
- 82.85 – 192.47
- Day range
- 93.01 – 96.77
- Volume / Avg
- 875.30K / 682.68K
- Beta
- —
- Shares outstanding
- 33.62M
52-week range
IRTC stock today
iRhythm (IRTC) closed at $94.72 on Nov 20, up 0.51% (+$0.48), versus the S&P 500's 3.70% decline. At this level, IRTC sits near the bottom of its 52-week range of $82.85 to $192.47: 50.8% below the high, set on Nov 26, 2025 and 14.3% above the low. IRTC is down 46.6% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 46.7%.
iRhythm has posted a net loss over the last twelve months (EPS of -$1.17), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About iRhythm
Company profileiRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Quentin S. Blackford
- Headquarters
- San Francisco, CA
- Employees
- 2,400
- IPO year
- 2016
- Website
- irhythmtech.com
Financial highlights
Full financialsIn fiscal 2025, iRhythm generated $747.1 million in revenue, up 26.2% from fiscal 2024, its 11th consecutive year of revenue growth. iRhythm reported a net loss of $44.6 million, compared with a loss of $113.3 million a year earlier. Gross margin was 70.6% (up from 68.9%) and operating margin -7.7%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $747.14M | $591.84M | $492.68M | $410.92M | $322.82M |
| Growth | +26.24% | +20.13% | +19.90% | +27.29% | +21.74% |
| Net income | $-44.55M | $-113.29M | $-123.41M | $-116.16M | $-101.36M |
| EPS (diluted) | $-1.39 | $-3.63 | $-4.04 | $-3.88 | $-3.46 |
Analyst forecast
ForecastConsensus (16 analysts)
strong_buy
Avg. price target
$153.27+61.81%
- Strong buy 3
- Buy 12
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $-0.06 vs $0.02
- Surprise
- -400.00%
IRTC news
All IRTC news- Friday 11/20 Insider Buying Report: IRTC, PLDNasdaqIRTC, PLD
- IRhythm Signs $100 Mln Accelerated Share Buyback Agreement With JPMorganNasdaqIRTC, JPM, BF.A
- iRhythm Technologies, Inc. Enters into $100.0 million Accelerated Share Repurchase AgreementNasdaq
- iRhythm kicks off $100M accelerated share repurchase deal with JPMorganSeeking Alpha
- iRhythm Announces $100 Million Accelerated Share Repurchase AgreementGlobeNewswire
- BTIG sees upside across medtech stocks as iRhythm, Delcath and MiniMed stand outInvesting.comMMED, IRTC
- iRhythm Technologies, Inc. Announces $200.0 Million Share Repurchase ProgramNasdaq
- IRhythm Approves $200 Mln Share Buy-Back For Operational ExpensesNasdaqIRTC, LEN.B
iRhythm peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PLSEPulse Biosciences Inc | 45.55 | +2.57% | $3.35B | vs IRTC |
| ATRCAtriCure Inc. | 55.39 | +2.37% | $2.82B | vs IRTC |
| NVSTEnvista Holdings Corporation | 22.91 | -1.55% | $3.67B | vs IRTC |
| UFPTUFP Technologies Inc. | 290.85 | -2.70% | $2.25B | vs IRTC |
| HTFLHeartflow Inc. | 46.69 | +4.62% | $4.10B | vs IRTC |
| STVNStevanato Group S.p.A. | 15.65 | -1.76% | $4.27B | vs IRTC |
| ICUIICU Medical Inc. | 172.52 | -1.84% | $4.31B | vs IRTC |
| MMEDMiniMed Group Inc. | 16.01 | -1.54% | $4.50B | vs IRTC |
Indexes, lists and sector
iRhythm stock FAQ
What is iRhythm's stock price today?
IRTC last traded at $94.72 as of Nov 20, 4:00 PM EST, up 0.51% on the day. Prices are delayed at least 15 minutes.
Who is iRhythm's CEO?
Mr. Quentin S. Blackford is the chief executive officer of iRhythm Holdings Inc., which has about 2,400 employees.
What is the IRTC 52-week high?
The 52-week high for IRTC is $192.47 and the 52-week low is $82.85. The stock is currently 50.8% below its high.